Pierre Chancel - Articles and news items


FDA accepts Sanofi’s New Drug Application for basal insulin Toujeo®

Industry news / 8 July 2014 / Sanofi

Sanofi announced that the U.S. Food and Drug Administration has accepted for review the company’s New Drug Application for Toujeo®…


Sanofi reports positive Phase 3 results for Toujeo®

Industry news / 19 June 2014 / Sanofi

Sanofi announced that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) consistently showed significantly fewer low blood sugar events (hypoglycemia)…

Sanofi announces new phase 3 results for investigational new insulin U300

Industry news / 3 December 2013 / Sanofi

EDITION II trial demonstrates similar blood sugar control with fewer night-time low blood sugar events for U300 compared with Lantus®…


Lyxumia® is first diabetes therapy of its class approved in Japan for use in combination with basal insulin

Industry news, News / 28 June 2013 / Sanofi

Japan’s MHLW has approved the manufacturing and distribution of Lyxumia®…


Sanofi announces positive Phase 3 results for investigational new insulin U300

Industry news, News / 22 June 2013 / Sanofi

Topline results of EDITION II consistent with EDITION I findings…


Sanofi New Drug Application for Lixisenatide accepted for review by FDA

Industry news, News / 19 February 2013 / Sanofi

Sanofi announced that the U.S. FDA has accepted for review a New Drug Application for lixisenatide…


Once-daily Lyxumia® (lixisenatide) approved for treatment of type 2 diabetes in Europe

Industry news, News / 4 February 2013 / Sanofi

Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist…


Sanofi receives positive CHMP opinion in the European Union for once-daily Lyxumia® (lixisenatide)

Industry news, News / 16 November 2012 / Sanofi

“The CHMP positive opinion for Lyxumia marks an important milestone…”

Sanofi to launch state-of-the art, reusable insulin pen AllStar™ in India

Industry news, News / 9 October 2012 / Sanofi

Sanofi announced the launch by Sanofi India Limited of AllStar™…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...